Showing results (841-850 of 6,955) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|May 20, 2005
Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgeryOlaf Burkhardt, Jolanta Majcher-Peszynska, Klaus Borner, et al.Journal of Clinical Pharmacology|September 3, 2004
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activityNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.Journal of Clinical Pharmacology|September 3, 2004
Pharmacokinetics of frovatriptan in adolescent migraineursArthur H Elkind, Andrew Wade, Gary IshkanianJournal of Clinical Pharmacology|August 3, 2004
Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38Luca Paoluzzi, Arun S Singh, Douglas K Price, et al.Journal of Clinical Pharmacology|August 3, 2004
Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemiaMary Buckwalter, James A Dowell, Joan Korth-Bradley, et al.Journal of Clinical Pharmacology|August 3, 2004
Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteersGary T Emmons, Rick Argenti, Louis L Martin, et al.Journal of Clinical Pharmacology|March 22, 2005
Origin and uses of primum non nocere--above all, do no harm!Cedric M SmithJournal of Clinical Pharmacology|March 22, 2005
Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypesHongxia Zheng, Erin Schuetz, Adriana Zeevi, et al.Journal of Clinical Pharmacology|March 22, 2005
Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokineticsWendy S Putnam, Jonathan M Woo, Yong Huang, et al.Journal of Clinical Pharmacology|April 16, 2005
Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteersJ A Wagner, P J Larson, S Weiss, et al.Pageof 696